Tokushima, Japan

Kenji Kitazato

This inventor holds 5 USPTO granted patents. Top assignees: Taiho Pharmaceutical Company Limited, Taisho Pharmaceutical Co., Ltd.. Active years: 1978-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kenji Kitazato. Retrieved from https://idiyas.com/inventor/kenji-kitazato

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 80.0

Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 8(Granted Patents)


Location History:

  • Tokushima, JA (1978)
  • Tokushima, JP (1983 - 2003)

Company Filing History:


Years Active: 1978-2003

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Kenji Kitazato: Innovator in Pharmaceutical Research

Introduction

Kenji Kitazato is a notable inventor based in Tokushima, Japan. He has made significant contributions to the field of pharmaceutical research, particularly in the development of compositions aimed at combating serious health issues.

Latest Patents

Kenji Kitazato holds 5 patents to his name. His latest patents include innovative solutions such as Anti-HIV compositions and a Vascular intimal hyperplasia-inhibitory composition. These inventions reflect his commitment to advancing medical science and improving patient outcomes.

Career Highlights

Throughout his career, Kitazato has worked with prominent companies in the pharmaceutical industry. He has been associated with Taiho Pharmaceutical Company Limited and Taisho Pharmaceutical Co., Ltd. His work in these organizations has allowed him to contribute to various groundbreaking projects.

Collaborations

Kitazato has collaborated with esteemed colleagues, including Norio Unemi and Setsuro Fujii. These partnerships have fostered an environment of innovation and have led to the development of impactful pharmaceutical solutions.

Conclusion

Kenji Kitazato's contributions to pharmaceutical research and his innovative patents highlight his role as a key figure in the industry. His work continues to inspire advancements in medical treatments and therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…